T2 Biosystems Inc. (TTOO)
0.23
0.00 (2.18%)
At close: Feb 20, 2025, 3:48 PM
undefined% (undefined)
| Bid | 0.12 |
| Market Cap | 6.34M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -0.03 |
| PE Ratio (ttm) | -7.53 |
| Forward PE | n/a |
| Analyst | Hold |
| Ask | 0.12 |
| Volume | 504,128 |
| Avg. Volume (20D) | 1,585,962 |
| Open | 0.22 |
| Previous Close | 0.23 |
| Day's Range | 0.18 - 0.24 |
| 52-Week Range | 0.06 - 6.80 |
| Beta | undefined |
About TTOO
T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine. The company also offers T2Dx Instrument, a bench-top instrument that runs various diagn...
Industry Medical - Diagnostics & Research
Sector Healthcare
IPO Date Aug 7, 2014
Employees 113
Stock Exchange NASDAQ
Ticker Symbol TTOO
Website https://www.t2biosystems.com
Analyst Forecast
According to 1 analyst ratings, the average rating for TTOO stock is "Hold." The 12-month stock price forecast is $5, which is an increase of 2112.39% from the latest price.
Buy 0.00%
Hold 100.00%
Sell 0.00%
Next Earnings Release
T2 Biosystems Inc. is scheduled to release its earnings on Mar 4, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
9 months ago
+43.51%
T2 Biosystems shares are trading higher after the ...
Unlock content with
Pro Subscription
9 months ago
-2.42%
T2 Biosystems shares are trading higher after the company reported mixed Q1 financial results and announced the execution of a territory exclusive distribution agreement in Qatar.
